Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Pneumonia with Elevated Presepsin (INSPIRE)
NCT05785442Phase 2Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Mar 2023
- Primary completion
- Jun 2024
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in community acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), sponsored by Hellenic Institute for the Study of Sepsis. Started Mar 2023; status: completed.
02
Drugs
anakinra
03
Conditions
community acquired pneumonia (CAP)hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on NCT05785442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05785442.